Moviprep (Ascorbic Acid, Sodium Ascorbate, Potassium Chloride, Sodium Chloride, Sodium Sulfate Anhydrous, Macr)

Moviprep, an osmotic laxative used for bowel preparation, is indicated for the following clinical situations:

• Colonoscopy preparation: provides rapid bowel evacuation to allow clear visualization of the colon.
• Flexible sigmoidoscopy preparation: clears the distal colon for accurate endoscopic assessment.
• Radiologic imaging of the colon: ensures the colon is free of stool for optimal imaging quality.

• Moviprep contains polyethylene glycol and electrolytes that remain largely unabsorbed in the gastrointestinal tract. By creating an osmotic gradient, it retains water and electrolytes within the intestinal lumen, increasing intraluminal fluid volume. The resulting distension stimulates peristalsis and leads to rapid, complete evacuation of colonic contents, facilitating bowel cleansing.

Common side effects are generally mild and related to the gastrointestinal tract.

Common Side Effects

• Nausea: transient feeling of sickness.
• Abdominal bloating: sensation of fullness or swelling.
• Cramping: intermittent abdominal pain.
• Vomiting: occasional expulsion of stomach contents.
• Thirst: increased desire for fluids.
• Mild electrolyte changes: slight shifts in sodium or potassium levels.

Serious or Rare Side Effects

• Severe dehydration: marked fluid loss requiring medical attention.
• Significant electrolyte imbalance: hypokalemia or hypernatremia that may affect cardiac function.
• Severe abdominal pain: persistent, intense pain.
• Allergic reaction: rash, itching, or swelling.
• Anaphylaxis: rare, life‑threatening hypersensitivity.
• Colonic perforation: extremely rare tearing of the colon wall.

Before prescribing Moviprep, clinicians should consider several safety aspects.

• Assess renal function: impaired kidneys may affect fluid and electrolyte handling.
• Review baseline electrolytes: monitor potassium and sodium levels.
• Avoid in bowel obstruction: risk of increased intraluminal pressure.
• Use cautiously in inflammatory bowel disease: may exacerbate symptoms.
• Pregnancy: safety not established; weigh benefits against potential risks.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Moviprep may interact with other medicines that influence fluid balance or electrolyte status.

Major Interactions (Avoid)

• Other osmotic laxatives: additive risk of severe dehydration and electrolyte loss.
• Loop diuretics: may exacerbate fluid depletion and electrolyte disturbances.
• Lithium: fluid shifts can alter lithium concentrations, risking toxicity.

Moderate Interactions (Monitor Closely)

• Anticholinergic agents: may reduce the efficacy of bowel cleansing.
• NSAIDs: combined use may increase risk of renal impairment.
• ACE inhibitors: monitor renal function and electrolytes during co‑administration.